Luke O'Neill
👤 SpeakerVoice Profile Active
This person's voice can be automatically recognized across podcast episodes using AI voice matching.
Appearances Over Time
Podcast Appearances
And that was unusual because it's a drug that's widely used.
It's a strange thing, you know.
So, obviously, they know it's side effects and safety.
Yeah, freely available.
So, freely available.
But that will be used immediately, watch, because it's freely available.
And what's the other development?
This is more exciting because this is more experimental.
GSK, the drug company, give them credit.
A drug called Mores.
Now, there's a mouthful for you.
They developed this drug called Mores and they got a 62% response rate, which meant 62% of people responded really well.
Their tumours shrank and were eliminated.
Yeah.
With ovarian cancer.
Eliminate.
Yeah, and some of these people with this drug, and it's a very powerful drug.
In ovarian cancer, the cancer cells overexpress a thing called B7H4 on their surface, like a flag goes up on the cancer cell.
Yeah.
This was a drug, an antibody that could lock onto that.